Multiple sclerosis (MS) is a chronic and debilitating autoimmune disease of the central nervous system (CNS) that affects approximately 400,000 individuals in the United States and 2 million individuals worldwide. MS occurs in two forms â progressive (primary or secondary) and relapse-remitting, and many patients with relapse-remitting forms often develop a more progressive, non-remitting disorder later in life. Although the etiology of MS is unknown, women and individuals of countries in northern latitudes have a greater incidence of MS; deficiencies in vitamin D absorption and some genetic instability are traits associated with the disorder. MS is a triphasic disease involving astrocyte activation that leads to inflammation and recruitment of activated T cells to the CNS, and subsequent demyelination, axonal damage, and neurodegeneration.
The Journal of Multiple Sclerosis (JMSO) is an academic journal that promises peer review process for the submitted manuscripts for the quality of publishing. The journal aims to publish most reliable and updated information based on research findings and current developments. The journal is a freely accessible online journal having original articles, review articles, case reports, short communications, in every released issue.
Last date updated on November, 2020